Viroclinics Biosciences

Viroclinics Biosciences is a leading contract research and clinical laboratory services company providing diagnostics, preclinical research, and drug development for the prevention and treatment of viral infections. With their extensive experience in respiratory viruses, particularly influenza viruses, Viroclinics Biosciences’ mission is to serve the biopharmaceutical community by offering cutting-edge diagnostic technologies, customized models for (preclinical) drug testing, and expert advice on antiviral and vaccine development for both human and animal health. Viroclinics Biosciences offers a full range of virology services for new drug development programs as well as post-marketing surveillance of existing drugs and vaccines, spanning from traditional virology assays to state-of-the-art deep sequencing protocols for various viruses. Their BSL2 and BSL3 laboratories enable them to perform analyses in accordance with international ISO 15189 certification. Close collaboration with the Erasmus MC Viroscience Laboratory brings comprehensive benefits of knowledge, experience, and expertise to their work.